The relation of breast cancer staging to screening protocol compliance: A computer simulation study

Computers in Biology and Medicine

Volumn 35, Issue 2, 2005, Pages 91-101

  Castro, Frank ^a   Carter, Kimbroe J ^a,b   Kessler, Edward ^a   Erickson, Barbara A ^a   Kseibi, Samer A ^a  

^a ST ELIZABETH HEALTH CENTER   (United States)

^b NONE   (United States)

Author keywords

Breast cancer screening; Compliance; Computer simulation; Sub clinical disease; Thresholds; TNM staging

Indexed keywords

COMPUTER SIMULATION; DISEASES; MATHEMATICAL MODELS; POPULATION STATISTICS; RELATIONAL DATABASE SYSTEMS;

BREAST CANCER; SCREENING PROTOCOL;

TUMORS;

ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CLINICAL PROTOCOL; COMPUTER MODEL; COMPUTER SIMULATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; THEORETICAL MODEL;

ADULT; BREAST NEOPLASMS; CLINICAL PROTOCOLS; COMPUTER SIMULATION; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MODELS, THEORETICAL; NEOPLASM STAGING; PATIENT COMPLIANCE;

EID: 9644263966     PISSN: 00104825     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.compbiomed.2003.12.006     Document Type: Article

References (32)

1. Zoorob R., Anderson R., Cefalu C., Sidani M. Cancer screening guidelines. Am. Fam. Physician. 63:2001;1101-1112
2. Tabar L., Duffy S.W., Vitak B., Chen H.H., Prevost T.C. The natural history of breast carcinoma. what have we learned from screening? Cancer. 86:1999;449-462
3. Tabar L., Vitak B., Chen H.H., Yen M.F., Duffy S.W., Smith R.A. Beyond randomized controlled trials. organized mammographic screening substantially reduces breast carcinoma mortality Cancer. 91:2001;1724-1731
4. Eddy D.M. Screening for Cancer: Theory, Analysis, and Design. 1980;Prentice-Hall, Englewood Cliffs, NJ
5. Miller A.B., Baines C.J., To T., Wall C. Canadian national breast screening study. 1. Breast cancer detection and death rates among women aged 40 to 49 years Can. Med. Assoc. J. 147:1992;1459-1476
6. Miller A.B., Baines C.J., To T., Wall C. Canadian national breast screening study. 2. Breast cancer detection and death rates among women aged 50 to 59 years Can. Med. Assoc. J. 147:1992;1477-1488
7. Ikeda D.M., Andersson I., Wattsgard C., Janzon L., Linell F. Interval carcinomas in the malmo mammographic screening trial. radiographic appearance and prognostic considerations AJR. 159:1992;287-294
8. Tabar L., Faberberg G., Day N.E., Holmberg L. What is the optimum interval between mammographic screening examinations? - an analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br. J. Cancer. 55:1987;547-551
9. Tabar L., Duffy S.W., Krusemo U.B. Detection method, tumour size and node metastases in breast cancers diagnosed during a trial of breast cancer screening. Eur. J. Cancer Clin. Oncol. 23:1987;959-962
10. Sickles E.A., Kopans D.B. Deficiencies in the analysis of breast cancer screening data. J. Natl. Cancer Inst. 85:1993;1621-1624
11. Humphrey L.L., Helfand M., Chan B.K., Woolf S.H. Breast cancer screening. a summary of the evidence for the US preventive services task force Ann. Intern. Med. 137:2002;347-360
12. Fletcher S.W., Black W., Harris R., Rimer B.K., Shapiro S. Report of the international workshop on screening for breast cancer. J. Natl. Cancer Inst. 85:1993;1644-1656
13. Kerlikowske K., Grady D., Rubin S., Sandrock C., Ernster V.L. Efficacy of screening mammography. a meta-analysis JAMA. 273:1995;149-154
14. Shwartz M. An analysis of the benefits of serial screening for breast cancer based upon a mathematical model of the disease. Cancer. 41:1978;1550-1564
15. Chen H.H., Thurfjell E., Duffy S.W., Tabar L. Evaluation by Markov chain models of a non-randomised breast cancer screening programme in women aged under 50 years in Sweden. J. Epidemiol. Comm. Health. 52:1998;329-335
16. Duffy S.W., Day N.E., Tabar L., Chen H.H., Smith T.C. Markov models of breast tumor progression. some age-specific results J. Natl. Cancer Inst. Monogr. 22:1997;93-97
17. Prevost T.C., Rohan T.E., Duffy S.W., Chen H.H., To T., Hill R.D. Markov chain models and estimation of absolute progression rates. application to cataract progression in diabetic adults J. Epidemiol. Biostat. 4:1999;337-344
18. Habbema J.D.F., van Oortmarssen G.J., Lubbe J.Th.N., van der Maas P.J. The MISCAN simulation program for the evaluation of screening for disease. Comput. Methods Programs Biomed. 20:1984;79-93
19. van Oortmarssen G.J., Habbema J.D.F., van der Maas P.J., de Koning H.J., Collette H.J.A., Verbeek A.L.M., et al. A model for breast cancer screening. Cancer. 66(7):1990;1601-1612
20. Spratt J.S., Greenberg R.A., Heuser L.S. Geometry, growth rates, and duration of cancer and carcinoma in situ of the breast before detection by screening. Cancer Res. 46:1986;970-974
21. Shen Y., Zelen M. Screening sensitivity and sojourn time from breast cancer early detection clinical trials. mammograms and physical examinations J. Clin. Oncol. 19:2001;3490-3499
22. Walter S.D., Day N.E. Estimation of the duration of a pre-clinical disease state using screening data. Am. J. Epidemiol. 118(6):1983;865-886
23. Gould M.N., Jirtle R., Crowley J., Clifton K.H. Reevaluation of the number of cells involved in the neutron induction of mammary neoplasms. Cancer Res. 38:1978;189-192
24. Carter K.J., Castro F., Kessler E., Erickson B. A computer model for the study of breast cancer. Comput. Biol. Med. 33:2003;345-360
25. American Joint Committee on Cancer, Manual for Staging Cancer, 4th Edition, PA, J.B. Lippincott Company, 1992.
26. American Joint Committee on Cancer, AJCC Cancer Staging Manual, 5th Edition, Lippincott Williams & Wilkins, PA, 1997.
27. Tabar L., Chen H.H., Duffy S.W., Yen M.F., Chiang C.F., Dean P.B., et al. A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-. 14 mm invasive breast cancers a prospective study Lancet. 355:2000;429-433
28. Paci E., Duffy S.W., Giorgi D., Zappa M., Crocetti E., Vezzosi V., et al. Quantification of the effect of mammographic screening on fatal breast cancers. the florence programme 1990-1996 Br. J. Cancer. 87:2002;65-69
29. Duffy S.W., Tabar L., Chen H.H., Holmqvist M., Yen M., Abdsalah S., et al. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer. 95:2002;458-469
30. Miller A.B., To T., Baines C.J., Wall C. Canadian National Breast Screening Study-2. 13-year results of a randomized trial in women aged 50-59 years J. Natl. Cancer Inst. 92:2000;1490-1499
31. Olsen O., Gotzsche P.C. Cochrane review on screening for breast cancer with mammography. Lancet. 358:2001;1340-1342
32. Miller A.B., To T., Baines C., Wall C. The Canadian national breast screening study-1. breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years Ann. Intern. Med. 137:2002;361-362